140 related articles for article (PubMed ID: 9688432)
21. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
Rao YV; Reddy KS; Wasir HS
Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
[TBL] [Abstract][Full Text] [Related]
22. Acute effects of nifedipine versus isosorbide dinitrate on exercise tolerance in patients with isolated coronary artery occlusion and collaterals.
Barillà F; Pelliccia F; Valente A; Cianfrocca C; Romeo F; Reale A
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():905-8. PubMed ID: 2076398
[TBL] [Abstract][Full Text] [Related]
23. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
[TBL] [Abstract][Full Text] [Related]
24. Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates.
van de Ven LL; Vermeulen A; Tans JG; Tans AC; Liem KL; Lageweg NC; Lie KI
Int J Cardiol; 1995 Jan; 47(3):217-23. PubMed ID: 7721498
[TBL] [Abstract][Full Text] [Related]
25. Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris.
Nesto RW; White HD; Wynne J; Holman BL; Antman EM
Am J Cardiol; 1987 Aug; 60(4):256-61. PubMed ID: 3618486
[TBL] [Abstract][Full Text] [Related]
26. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
Akhras F; Jackson G
Lancet; 1991 Oct; 338(8774):1036-9. PubMed ID: 1681355
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation and comparison of five antianginal treatments by means of a bicycle ergometer exercise test (author's transl)].
Borgioni L; Medugno G; Riavez R; Scardi S; Camerini F
G Ital Cardiol; 1976; 6(6):994-1007. PubMed ID: 798709
[TBL] [Abstract][Full Text] [Related]
29. Withdrawal phenomenon after abrupt cessation of nifedipine in stable angina pectoris.
Martsevich SY; Koutishenko N; Metelitsa VI
Int J Cardiol; 1993 Dec; 42(3):298-301. PubMed ID: 8138342
[TBL] [Abstract][Full Text] [Related]
30. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
Thadani U; Fung HL; Darke AC; Parker JO
Am J Cardiol; 1982 Feb; 49(2):411-9. PubMed ID: 7058754
[TBL] [Abstract][Full Text] [Related]
31. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
[TBL] [Abstract][Full Text] [Related]
32. [The nifedipine withdrawal syndrome in patients with stable stenocardia of effort].
Martsevich SIu; Kutishenko NP; Metelitsa VI
Ter Arkh; 1995; 67(6):8-10. PubMed ID: 7667792
[TBL] [Abstract][Full Text] [Related]
33. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
34. Relation of antianginal efficacy of nifedipine to degree of coronary arterial narrowing and to presence of coronary collateral vessels.
Schulz W; Jost S; Kober G; Kaltenbach M
Am J Cardiol; 1985 Jan; 55(1):26-32. PubMed ID: 3881006
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
[TBL] [Abstract][Full Text] [Related]
36. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.
Parker JO; VanKoughnett KA; Fung HL
Am J Cardiol; 1984 Jul; 54(1):8-13. PubMed ID: 6430057
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of isosorbide dinitrate and nifedipine in the treatment of variant angina pectoris. Randomized study].
Aschermann M; Bultas J; Karetová D; Kölbel F; Simper D; Kozáková M
Cas Lek Cesk; 1989 Sep; 128(37):1178-81. PubMed ID: 2805034
[TBL] [Abstract][Full Text] [Related]
38. Coronary dilator effects of intracoronary nifedipine and isosorbide dinitrate.
Griffin B; Timmis AD; Sowton E
Eur Heart J; 1987 Nov; 8 Suppl K():69-74. PubMed ID: 3450523
[TBL] [Abstract][Full Text] [Related]
39. Rebound of vasospastic angina after cessation of long-term treatment with nifedipine.
Lette J; Gagnon RM; Lemire JG; Morissette M
Can Med Assoc J; 1984 May; 130(9):1169-71, 1174. PubMed ID: 6713338
[TBL] [Abstract][Full Text] [Related]
40. Nitrate tolerance.
Parker JO
Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
